What Pollen.com does

Pollen.com is a consumer-facing allergy and pollen forecasting platform operating across the continental United States, wholly owned by IQVIA, a healthcare data and analytics conglomerate. The platform provides real-time pollen counts, 5-day localized forecasts, historical trend analysis, and email/mobile alert services to individual allergy sufferers, drawing on a target market of more than 67 million Americans affected by seasonal allergies. Its technical foundation rests on the patented Rotorod pollen collection device, which uses a rotating rod with a sticky surface to gather air samples over 24-hour periods, with microscopic analysis yielding standardized pollen concentration data across the network.

The product surface spans a self-serve web platform (pollen.com), a My Pollen.com personalized dashboard with an Allergy Diary, Allergy Alert email notifications triggered at index 4.0, and iOS mobile applications. Supplementary modules include a research database covering over 1,200 allergenic plant species, a doctor search tool, allergy news sourced from HealthDay News, and cross-platform integrations with Flustar.com (cold/flu forecasts) and Asthmaforecast.com (asthma forecasts). The platform integrates weather data from NOAA and Weather Trends to support predictive forecasting.

Pollen.com operates a freemium consumer model with no disclosed subscription fees or pricing tiers; revenue is implicitly advertising-driven (visible ad slots on the platform), supplemented by the strategic value the asset delivers to IQVIA's broader healthcare data ecosystem. Distribution is product-led and SEO-driven, with no enterprise sales motion, no disclosed API, and no external funding. The company reports 251–500 employees and was founded in 1954, making it one of the longest-operating allergy information platforms in the United States.

Name

Pollen.com

Legal name

Pollen.com

Website

https://pollen.com

Company type

Private

Founded year

1954

Operating status

Operating

Headcount range

251–500 employees

Short description

Pollen.com is a US consumer allergy and pollen forecasting platform owned by IQVIA, providing real-time pollen counts, 5-day forecasts, email alerts, and historical trend data to individual allergy sufferers across the continental United States.

Ownership category

akta.pro rank

Product category

Allergy Forecasting & Health Information Services

akta.pro primary industry

Allergen Immunotherapy (SCIT/SLIT) Services (HLAKAAAF)

akta.pro secondary industry

Biological Exposure Monitoring (Bioaerosols, Mold, Pathogens) (EUAHAGAF)

Keywords

• Allergy forecasting
• Pollen forecasts
• Allergy alerts
• Pollen monitoring
• Airborne allergen data

Headquarters

HQ city

Mountain View

HQ country

United States

HQ region

North America

Markets served

GTM type

B2C

Offering type

Digital Commerce or Content

Cost components

Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Consumer Allergy Information Services: Free pollen forecasting and allergy information services for consumers. The site offers local pollen forecasts, allergy alerts, and educational content. Revenue may be generated through advertising displayed on the platform.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels4 records

Core offering

Pollen.com provides free, location-based allergy and pollen forecasts for consumers across the continental United States via its web platform, email alerts, and iPhone applications. The service combines current and historical pollen counts with weather data to deliver 5-day allergy outlooks, personalized symptom diaries, and email notifications when conditions reach moderate levels. Pollen.com also manufactures the patented Rotorod® pollen collection device used to gather the underlying air-sample data and maintains a research database of more than 1,200 allergenic plant species.

Product overview

Pollen.com is a health weather forecasting platform providing pollen, allergy, cold/flu, and asthma predictions. The core offering is a location-based allergy forecasting platform consisting of the My Pollen.com dashboard, Current Allergy Report, 5-Day Allergy Forecast, Allergy Diary, and Allergy Alert Email service. The platform also offers supplementary modules including Historical Pollen Data, Annual Pollen Trends, Doctor Search, Allergy News, and cross-platform integrations for Cold & Flu Forecast and Asthma Forecast. Pollen.com also manufactures the Rotorod® patented pollen collection device and provides a Research database covering over 1,200 allergenic plant species. The platform is owned by IQVIA™.

Differentiator

Problem solved

Functional benefit

Brands

• Rotorod: Patented pollen collection device for accurate pollen counts

Products and services

• Pollen.com Allergy Forecast Platform

Quantifiable outcome

• Provides pollen forecasts for every area in the continental United States
• +1 more outcomes

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration4 records

AI capability3 records

Feature1 record

Scale indicators1 record

Recent moves5 records

Expansion highlights4 records

Direct peers

• AccuWeather: AccuWeather is a major consumer weather-forecasting platform that includes pollen and allergy forecasts within its broader weather experience, directly competing with Pollen.com's core offering of location-based allergy reporting and email/mobile alerts.
• Weather Underground: Weather Underground provides hyperlocal weather information including allergy forecasts, sharing Pollen.com's product-led model of free ad-supported consumer weather and health forecasting.
• The Weather Channel (weather.com): The Weather Company / weather.com offers pollen and allergy forecasts integrated into general weather content, mobile app, and email alerts — competing head-on with Pollen.com for free, ad-supported pollen forecast traffic.

Emerging players

• IQ Air (AirVisual): IQ Air provides consumer and enterprise air-quality and pollen monitoring with global coverage; it overlaps with Pollen.com's biological exposure monitoring scope and represents an adjacent commercial player in environmental health forecasting.

Others

• Zyrtec (Johnson & Johnson consumer allergy): Zyrtec's allergy hub offers allergy-tracking and educational content overlapping Pollen.com's educational articles, doctor search, and allergy-diary offerings — competing for the same allergy-sufferer attention.
• Clorox (Burt's Bees, allergen-reduction consumer products): Clorox markets household allergen-management products alongside health-content resources; it is an ecosystem-adjacent player to Pollen.com within the broader consumer-allergy value chain.
• IQVIA: IQVIA is Pollen.com's parent company and a healthcare data and analytics conglomerate; it is the corporate parent and broader ecosystem owner of the platform rather than a direct competitor, but its strategy and resources directly shape Pollen.com's trajectory.
• Flonase (GSK consumer allergy products): Flonase and similar OTC allergy brand sites offer allergy-tracking tools and forecasts as part of consumer engagement with their products; they overlap thematically with Pollen.com's symptom tracking and forecast content.

Broad incumbents

• AirNow (U.S. EPA): AirNow is a federal air-quality monitoring platform that publishes pollen and air-quality data nationwide; while not a commercial competitor, it represents the public-sector incumbent that adjacent biological-exposure forecasting services must coexist with.
• WebMD: WebMD is a major consumer health-information platform where users seeking allergy guidance often begin — competing for the same health-seeking user intent that Pollen.com's allergy articles, news, and doctor-search tools target.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Pollen.com